Fundraising FoxNovilytic
West Lafayette, US · Indiana LLC · 2 known investors
Find your way into Novilytic
Sign up to see every warm intro you have to Novilytic
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Novilytic team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Novilytic develops a simplified analytical testing system using a single HPLC instrument with fluorescence detection and proprietary Proteometer Kit to replace multiple instruments and personnel traditionally required for R&D analytical work in chemistry.
Founders & leadership
FR
Fred RegnierPurdue University Professor Emeritus
RW
Rich WynneChief Financial OfficerRich Wynne has worked in investment banking and private equity, with experience in portfolio management, valuations, and capital raising. He holds an MBA in Finance from Indiana University–Bloomington, a Bachelor's degree in History from Northwestern University, and a CPA license from Indiana.
PC
Paul C DreierNamed on SEC filing
JA
Jiri AdamecNamed on SEC filing
Board
AS
Alan SymonsBoard director
EW
Edward W WoenkerBoard director
TE
Timothy E WoenkerBoard director
JE
Johnston ErwinBoard director
JE
Jonathan EdwardsenBoard director
Investors · 2
Elevate Ventureslisted by Elevate VenturesIndianapolis · $20K – $2M
How we know: a partner's Signal profile · funding news · novilytic.com · the VCSheet dataset · Not right? Tell us
Also in the syndicate · 1
Purdue Foundry
Funding
SEC filings, press & company announcements$1.5M disclosed across 2 of 3 rounds · 2021–2025
- Undisclosed amountseed roundMay 2022
Elevate Ventures, Purdue Foundry
Source ↗
▶$530.8KraisedDec 2025 · 8 investors · BiotechnologyRule 506(b)
▶$530.8KraisedDec 2025 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Johnston ErwinDirector
- Paul C DreierExecutive Officer, Director, Promoter
- Jonathan EdwardsenDirector
- Rich WynneExecutive Officer
- Alan SymonsDirector
- Edward W WoenkerDirector
- Timothy E WoenkerDirector
- Fred E RegnierExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $530.8K
- Minimum investment
- $25K
- Proceeds to insiders
- $75K
- First sale
- Dec 2025
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b
▶$950KraisedApr 2021 · 7 investors · BiotechnologyRule 506(b)
▶$950KraisedApr 2021 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward WoenkerDirector
- Fred RegnierDirector
- Paul DreierExecutive Officer, Director
- Timothy WoenkerDirector
- Jiri AdamecDirector
- Offering amount
- $3M
- Amount sold
- $950K
- Minimum investment
- $50K
- Proceeds to insiders
- $161.2K
- First sale
- Mar 2021
- Incorporated
- Limited Liability Company, Indiana
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
RevvityRevvity develops and sells reagents, instruments, software, and services for life sciences research and clinical diagnostics, serving pharmaceutical, biotech, academic and government institutions across drug discovery, development, and disease diagnosis workflows.
Fortis Life SciencesFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Intralytix
VeracyteVeracyte develops genomic diagnostic tests for cancer, offering laboratory developed tests for thyroid, prostate, bladder, and breast cancers performed in its CLIA-certified, high-complexity labs. Its tests analyze each patient's tumor biology to help clinicians make personalized treatment decisions.
Companies working in the same space as Novilytic.
In the news
Frequently asked questions
- What does Novilytic do?
- Novilytic develops a simplified analytical testing system using a single HPLC instrument with fluorescence detection and proprietary Proteometer Kit to replace multiple instruments and personnel traditionally required for R&D analytical work in chemistry.
- Who founded Novilytic?
- Novilytic was founded by Fred Regnier.
- Who are Novilytic's investors?
- Novilytic's investors include Elevate Ventures.
- How much funding has Novilytic raised?
- Novilytic has disclosed $1.5M raised across 2 of its 3 known rounds.
- Where is Novilytic headquartered?
- Novilytic is headquartered in West Lafayette, US.